Recent patient data surrounding this compound, specifically the 120 milligram formulation referred to as ZPHC, indicate a impressive effect on weight loss and related health conditions . Researchers posit that this combined compound, influencing both GLP-1 and GIP pathways , has the potential to offer a major improvement in the treatment of obesity